Yok-Ai Que
Has grant
Associate Professor and Senior Physician
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
What’s in a dose? Refining phage and antibiotic dosing for effective treatment of multidrug resistant bacterial infections
Open Date: 2022-11-01
Close Date: 2026-10-31
Grant: Close
Phage Therapy in Humans: Overview on Current Concepts in Europe and the Middle East
Open Date: 2022-08-01
Close Date: 2022-10-31
Grant: Close
Prophylaxis and Treatment of Staphylococcus spp. Intravascular and Extravascular Infections with Bacteriophages
Open Date: 2018-02-01
Close Date: 2022-01-31
Grant: Close
Prophylaxis and Treatment of Staphylococcus spp. Pneumonia and Catheter-related Infections with Bacteriophages
Open Date: 2018-01-01
Close Date: 2019-01-01
Grant: Close
In silico prediction of phage-bacteria infection networks as a tool to implement personalized phage therapy
Open Date: 2016-07-01
Close Date: 2019-12-31
Articles (10)
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Background The number of patients treated by ventricular assist devices (VAD) and the duration of VAD treatment is increasing. One of the main complications in terms of morbidity and mortality for VAD patients are microbial infections. With this study, we aimed to investigate the epidemiology and microbiological characteristics of infections occurring in a VAD population to identify modifiable factors. Methods We retrospectively analyzed patient characteristics, treatments and outcomes of VAD‐specific/related infections. All patients implanted in our institution with a continuous flow VAD between January 2009 and January 2019 were included. Risk factors for VAD infection were assessed using simple and multiple linear regressions. Results Of the 104 patients screened, 99 were included in the analysis, the majority of which were men (78%). At implantation, the mean age was 56 years and the median time on VAD support was 541 days. The overall infection rate per year per patient was 1.4. Forty‐seven patients (60%) suffered from VAD‐specific/related infection. Half of all infection episodes occurred in the first 4 months but the proportion of VAD‐specific/related infection was higher after the first 4 months (74% of all infection). Using regression models, no patient specific risk factors were associated with VAD‐specific/related infections. Conclusion No predictive factors for infection during VAD support were identified in this study. By extension, diabetes, renal insufficiency, age or high BMI are not sufficient to deny a patient access to ventricular support.
Year:
2022
Pseudomonas aeruginosa is a Gram-negative pathogen causing infections in acutely burned patients. The precise mechanisms required for the establishment of infection in the burn setting, and adaptive traits underpinning prolonged outbreaks are not known.
Year:
2022
Year:
2022
Year:
2022
Collaborators (15)
Renald Meçani
Medical University of Graz
Amy Tsurumi
Assistant Professor (2022-), Instructor (2019-22), Postdoc Fellow (2012-19)
Massachusetts General Hospital
Pierre-Olivier Bridevaux
Head of service
Université de Genève
Sebastian Robert Ott
Head of Departmebnt
St. Claraspital
Laura Naëmi Walti
University of Bern
André Moser
University of Bern
Martin Brutsche
Prof
Kantonsspital St. Gallen
Bruno Schnegg
-
Pedro David Wendel Garcia
University Hospital of Zurich
Christophe von Garnier
Head
Lausanne University Hospital
Taulant Muka
Stanford University
PETEK EYLUL TANERI
Ollscoil na Gaillimhe – University of Galway
Katja Schlegel
University of Bern
Sabina A. Guler
-
Marco Mancinetti
University of Fribourg
Make your next move.
Prepare your application
Review drafts before you send them.